NasdaqGS - Nasdaq Real Time Price USD

Omnicell, Inc. (OMCL)

25.99
+0.60
+(2.36%)
As of 10:11:13 AM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Randall A. Lipps Founder, Executive Chairman, President & CEO 2.17M -- 1957
Mr. Nchacha E. Etta Executive VP & CFO 1.02M -- 1972
Mr. Nnamdi N. Njoku Executive VP & COO 292.9k -- 1977
Mr. Corey J. Manley Executive VP, Chief Legal & Administrative Officer and Corporate Secretary 924.22k -- 1978
Mr. Brian H. Nutt VP, Chief Accounting Officer & Corporate Controller -- -- 1970
Dr. Perry A. Genova Ph.D. Senior VP & CTO -- -- --
Mr. Giri Chodavarapu Senior VP & Chief Information Officer -- -- --
Ms. Kathleen Nemeth Senior Vice President of Investor Relations -- -- --
Mr. Maximo Rocha Senior VP & Chief People Officer -- -- --
Ms. Minoo Mortazavi Senior Vice President of Global Operations -- -- --

Omnicell, Inc.

4220 North Freeway
Suite 301
Fort Worth, TX 76137
United States
877 415 9990 https://www.omnicell.com
Sector: 
Healthcare
Full Time Employees: 
3,670

Description

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Corporate Governance

Omnicell, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 4. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 7; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 30, 2025 at 12:30 PM UTC - August 4, 2025 at 12:30 PM UTC

Omnicell, Inc. Earnings Date

Recent Events

May 7, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 6, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 3, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 12, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 4, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 27, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 6, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 25, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 18, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 8, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers